RPE-MEDIATED MACULOPATHY

Clinical trials for RPE-MEDIATED MACULOPATHY explained in plain language.

Never miss a new study

Get alerted when new RPE-MEDIATED MACULOPATHY trials appear

Sign up with your email to follow new studies for RPE-MEDIATED MACULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cell therapy aims to slow vision loss in retinal disease

Disease control Recruiting now

This early-stage study tests a new treatment called C.001 for people with retinal diseases that cause vision loss, such as geographic atrophy and Stargardt disease. The treatment is given as a single injection into the eye. The main goal is to check if it is safe, and researchers…

Matched conditions: RPE-MEDIATED MACULOPATHY

Phase: PHASE1 • Sponsor: Cellio Therapeutics Inc • Aim: Disease control

Last updated Jun 12, 2026 12:05 UTC

RPE-MEDIATED MACULOPATHY

Get alerted when new RPE-MEDIATED MACULOPATHY trials appear

New cell therapy aims to slow vision loss in retinal disease